8-K: SRAX, Inc. Secures $75,000 in Funding Through Convertible Promissory Note

SRAX, Inc. has entered into an agreement to issue a convertible promissory note for $75,000, with a principal amount of $90,000, convertible into common stock at $0.25 per share.

Summary

• SRAX, Inc. has secured $75,000 in funding through the issuance of a convertible promissory note with a face value of $90,000, reflecting a 20% original issue discount.
• The note, due on February 28, 2026, does not accrue interest and is convertible into shares of SRAX's Class A common stock at an initial price of $0.25 per share.
• The conversion price is subject to adjustments for stock splits, dividends, rights offerings, pro-rata distributions, and certain fundamental transactions.
• The company has the option to prepay the note at 120% of the outstanding principal within the first 90 days, and 135% thereafter.
• The agreement includes standard default provisions, which, if triggered, would make the outstanding principal, liquidated damages, and other amounts immediately due and payable.

Sentiment

Score: 6

Explanation: The document indicates a necessary capital raise, but the terms are not overly favorable to the company. The high discount and potential dilution are concerning, but the funding is needed.

Positives

• The company has secured immediate funding of $75,000.
• The convertible note structure allows for potential future equity conversion, which could be beneficial for the company's capital structure.
• The prepayment option provides flexibility for the company to manage its debt.

Negatives

• The 20% original issue discount means the company receives less cash than the face value of the debt.
• The conversion of the note could dilute existing shareholders.
• The prepayment premium of 120% or 135% could be costly if the company chooses to prepay the note.

Risks

• The conversion of the note could significantly dilute existing shareholders.
• Failure to meet the terms of the note could trigger default provisions, leading to immediate repayment obligations.
• The company's ability to repay the note or manage its debt obligations is dependent on its future financial performance.
• The company may need to raise additional capital in the future, which could further dilute existing shareholders.

Future Outlook

The company has secured funding to support its operations, but its future financial health will depend on its ability to manage its debt and potentially convert the note into equity. The company has agreed to amend and restate the Certificate of Designation of Preferences of Rights and Limitations to the Series B NonVoting Convertible preferred to include the language in section 5b of this agreement to section 7 a of said agreement within 7 days of execution of this agreement.

Industry Context

This type of financing is common for companies seeking capital, particularly those that may not have access to traditional bank loans. The convertible note structure allows investors to participate in potential upside while providing the company with immediate funding.

Comparison to Industry Standards

• The 20% original issue discount is relatively high, suggesting the company may have had limited negotiating power or that the investor perceived a higher risk.
• The conversion price of $0.25 per share will be compared to the current market price of the stock to determine the value of the conversion option.
• The prepayment terms are fairly standard for this type of financing, with a premium required for early repayment.
• Other companies in similar situations have used similar financing methods, but the specific terms will vary based on the company's financial health and market conditions.

Stakeholder Impact

• Shareholders may experience dilution if the note is converted into equity.
• Creditors may be impacted by the terms of the note and the company's ability to repay its debt.
• Employees may be affected by the company's financial stability and future prospects.

Next Steps

• The company needs to manage its debt obligations and monitor the conversion price of the note.
• The company must ensure compliance with the terms of the note to avoid triggering default provisions.
• The company needs to amend and restate the Certificate of Designation of Preferences of Rights and Limitations to the Series B NonVoting Convertible preferred within 7 days of execution of this agreement.

Key Dates

Keywords

convertible note, promissory note, funding, debt financing, equity conversion, dilution, prepayment, default, SRAX, capital raise